DK151800C - Analogifremgangsmaade til fremstilling af et 2-phenylenmorpholinderivat, herunder dettes optiske isomere, eller et farmaceutisk acceptabelt syreadditionssalt deraf - Google Patents

Analogifremgangsmaade til fremstilling af et 2-phenylenmorpholinderivat, herunder dettes optiske isomere, eller et farmaceutisk acceptabelt syreadditionssalt deraf

Info

Publication number
DK151800C
DK151800C DK441080A DK441080A DK151800C DK 151800 C DK151800 C DK 151800C DK 441080 A DK441080 A DK 441080A DK 441080 A DK441080 A DK 441080A DK 151800 C DK151800 C DK 151800C
Authority
DK
Denmark
Prior art keywords
pharmaceutically acceptable
acid addition
acceptable acid
phenylene
analogue
Prior art date
Application number
DK441080A
Other languages
English (en)
Other versions
DK151800B (da
DK441080A (da
Inventor
Alan Chapman White
Edwin Trevor Edington
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of DK441080A publication Critical patent/DK441080A/da
Publication of DK151800B publication Critical patent/DK151800B/da
Application granted granted Critical
Publication of DK151800C publication Critical patent/DK151800C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Lubricants (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
DK441080A 1979-10-20 1980-10-17 Analogifremgangsmaade til fremstilling af et 2-phenylenmorpholinderivat, herunder dettes optiske isomere, eller et farmaceutisk acceptabelt syreadditionssalt deraf DK151800C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7936502 1979-10-20
GB7936502 1979-10-20

Publications (3)

Publication Number Publication Date
DK441080A DK441080A (da) 1981-04-21
DK151800B DK151800B (da) 1988-01-04
DK151800C true DK151800C (da) 1988-06-06

Family

ID=10508675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK441080A DK151800C (da) 1979-10-20 1980-10-17 Analogifremgangsmaade til fremstilling af et 2-phenylenmorpholinderivat, herunder dettes optiske isomere, eller et farmaceutisk acceptabelt syreadditionssalt deraf

Country Status (17)

Country Link
US (1) US4360519A (da)
EP (1) EP0027695B1 (da)
JP (1) JPS5665880A (da)
KR (2) KR840002427B1 (da)
AT (1) ATE4980T1 (da)
AU (1) AU531586B2 (da)
CA (1) CA1126731A (da)
DE (1) DE3065304D1 (da)
DK (1) DK151800C (da)
ES (1) ES8107201A1 (da)
FI (1) FI803277L (da)
GB (1) GB2061272B (da)
GR (1) GR70235B (da)
IE (1) IE50355B1 (da)
MY (1) MY8500468A (da)
PT (1) PT71940B (da)
ZA (1) ZA806017B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2125793B (en) * 1982-08-19 1985-10-02 Wyeth John & Brother Ltd Morpholine derivatives
GB8305638D0 (en) * 1983-03-01 1983-03-30 Wyeth John & Brother Ltd Morpholine derivatives
FR2553412B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8418657D0 (en) * 1984-07-21 1984-08-22 Beecham Group Plc Compounds
FR2581383A1 (fr) * 1985-05-03 1986-11-07 Cerm Cent Europ Rech Mauvernay 2-alkyl-2-aryl morpholines substituees, leur preparation et les compositions pharmaceutiques les contenant
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
CA2510785C (en) * 2002-12-19 2013-04-09 Merck & Co., Inc. Substituted amides
EP1636191A2 (en) 2003-06-17 2006-03-22 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
CA2646044A1 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
CA2670285A1 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
WO2009111004A1 (en) 2008-03-04 2009-09-11 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
ES2546492T3 (es) 2010-05-21 2015-09-24 Research Triangle Institute Derivados de 1-fenilmorfolina como análogos de hidroxibupropion para tratar drogodependencia
WO2011146850A1 (en) 2010-05-21 2011-11-24 Research Triangle Institute Phenylmorpholines and analogues thereof
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
MX2013002418A (es) 2010-09-01 2013-08-01 Arena Pharm Inc Administracion de lorcaserina a individuos con daño renal.
CN103189053A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 用于体重控制的5-ht2c激动剂的调节释放剂型
JP2013539470A (ja) 2010-09-01 2013-10-24 アリーナ ファーマシューティカルズ， インコーポレイテッド ロルカセリンと光学活性な酸との塩
SG188361A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
BR112015007779A2 (pt) 2012-10-09 2017-07-04 Arena Pharm Inc célula de fluxo de permeabilidade e sistema de condutância hidráulica

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997469A (en) * 1961-08-22 Preparation of substituted
US2835669A (en) * 1958-05-20 Process for the production of substi-
US3112311A (en) * 1957-04-05 1963-11-26 Geigy Chem Corp 2-phenyl-5, 6-dimethyl-morpholines and 2-phenyl-5, 6-tetramethylene-morpholines
US3296076A (en) * 1962-06-11 1967-01-03 Boehringer Sohn Ingelheim Pilomotor shaving compositions and method of using same
GB1336732A (en) * 1970-10-28 1973-11-07 Istituto Gentili Spa Pisa Diethanolamine derivatives
GB1452701A (en) * 1974-05-07 1976-10-13 Ici Ltd Morpholine derivatives

Also Published As

Publication number Publication date
ES496074A0 (es) 1981-10-01
ATE4980T1 (de) 1983-10-15
IE50355B1 (en) 1986-04-02
EP0027695A1 (en) 1981-04-29
AU6292280A (en) 1981-04-30
PT71940A (en) 1980-11-01
AU531586B2 (en) 1983-09-01
US4360519A (en) 1982-11-23
KR840002427B1 (ko) 1984-12-27
GB2061272B (en) 1983-08-10
ES8107201A1 (es) 1981-10-01
EP0027695B1 (en) 1983-10-12
MY8500468A (en) 1985-12-31
GB2061272A (en) 1981-05-13
PT71940B (pt) 1981-08-31
DE3065304D1 (en) 1983-11-17
ZA806017B (en) 1982-04-28
KR830004277A (ko) 1983-07-09
KR840002428B1 (ko) 1984-12-27
GR70235B (da) 1982-09-01
DK151800B (da) 1988-01-04
FI803277L (fi) 1981-04-21
DK441080A (da) 1981-04-21
JPS5665880A (en) 1981-06-03
CA1126731A (en) 1982-06-29
IE801995L (en) 1981-04-20

Similar Documents

Publication Publication Date Title
DK151800C (da) Analogifremgangsmaade til fremstilling af et 2-phenylenmorpholinderivat, herunder dettes optiske isomere, eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK164937C (da) Analogifremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater eller farmaceutisk acceptable syreadditionssalte deraf samt 1-alkyl-2-aminotetralinderivater til anvendelse som udgangsmateriale i fremgangsmaaden
DK163120C (da) Analogifremgangsmaade til fremstilling af substituerede acylderivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyre (s,s,s) eller et farmaceutisk acceptabelt salt deraf
DK149022C (da) Analogifremgangsmaade til fremstilling af aminderivater af di-o-(n-alkyl- eller alkenyl)-glyceroler eller farmaceutisk acceptable syreadditionssalte deraf
ES513108A0 (es) "procedimiento de preparacion de derivados de 1-fenil-1-hidroxi-etilamina".
ES530901A0 (es) Procedimiento para preparar derivados de piperazina
DK151627C (da) Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf.
SE8100403L (sv) Cyklohexen-derivat
DK420682A (da) Fremgangsmaade til fremstilling af triazoloquinazoloner eller salte deraf
DK156064C (da) Analogifremgangsmaade til fremstilling af 2,4-(1h,3h)-quinazolindionderivater eller farmaceutisk acceptable syreadditionssalte deraf
ES526089A0 (es) Un procedimiento para preparar derivados de ciclobutano
NO150436C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenylamino-imidazolin-derivater
SE7900601L (sv) 1-naftyl-ettiksyraderivat jemte forfarande for deras framstellning
ATE18211T1 (de) Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.
ES475120A1 (es) Un procedimiento para la preparacion de imidazo (1,5-b)piri-dazinas.
NO164901C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetraoxo-3,7-diazabicyclo (3,3,1)-nonanforbindelser.
ES8304532A1 (es) "procedimiento de preparacion de derivados de etanolamina".
DK573981A (da) Fremgangsmaade til fremstilling af cis-c-3",c4"-carbonatderivater af o-demethyl-oleandomycin og mellemprodukter herfor
ES8103742A2 (es) Un procedimiento de preparacion de nuevos derivados de 1,3-benzodioxina
DK379579A (da) Fr&mgangsmaade til fremstilling af et diuretisk middel
MX160562A (es) Un proceso para preparar derivados de cloruro de aninosulfenilo
ES500108A0 (es) Procedimiento para preparar nuevas benzotiopirano (2,3-c)pi-ridinas

Legal Events

Date Code Title Description
PBP Patent lapsed